Baar C. E. et al. [52] found that combining the HE4 assay with the currently used CA125 test as part of the ROMA algorithm improved the detection of ovarian cancer in primary care, particularly in women under 50 years of age, when the diagnosis is more difficult. This evidence concerns the gene MUC16 and ovarian cancer.